Although UOSS77 trended toward having greater efficacy, this did not reach statistical significance.
← all excerpts
Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias.
1
—
—